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Background: The number of patients affected by allergies is increasing worldwide and results in 
significant costs for health care and social systems. Allergic rhinitis (AR) is a common allergic disorder, 
affecting 10–20% of the population. Evidences suggest that the prevalence of the disorder is increasing. The 
body of knowledge regarding allergic rhinitis continues to expand, with rapid growth in the number of 
publications.  
Methods: A search of the database shows that the annual number of publications on AR has 
continued to grow. Therefore, systematizing and critically evaluating existing literature data provides a 
selective approach to clinicians. The most important information were obtained through the synthesis of the 
results of different clinical trials. Evidence-based reviews with recommendations were developed according 
to a significance level system using previously reported Rudmik and Smith methodology from 2011.  
Results: Data were collected from the analysis of randomized clinical trials, observational studies 
and studies covering a series of patients. Data relevant to the pathophysiology of allergic rhinitis, 
recommendations for diagnosis of AR and comorbidities associated with AR, as well as recommendations 
for pharmacological treatment of this disease, were analyzed. A schematic procedure for allergic rhinitis is 
also presented.  
Conclusion: The analysis of the obtained data yielded recommended procedures in the diagnosis of 
hypersensitivity, and optimal medical treatment in patients with AR. It also demonstrated the same gaps in our 
understanding of the pathophysiology of AR. 
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